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Plasmid construction.
For expression in E. coli, the α-GFP nanobody (Kirchhofer et al., 2010) , equipped with a Cterminal His 6 -tag for purification via metal ion affinity chromatography, was inserted into the pET21a(+) plasmid. For site-specific labeling, a free single cysteine was introduced C-terminally to the His 6 -tag. The α-GFP nanobody was PCR amplified by the following primers: fw 5'-GCGCGCAAGCTTAAGGAGATATACATATGCAGGTTCAGCTGGTTGAAA GCGGTGGTGCAC-3' (Hind III restriction site underlined, RBS italic, start codon bold); rev 5'-GCGCCTCGAGGTCAGCAGTGGTGATGGTGATGATGGCTGCTAACGGTAACCTGGGT GCCC-3' (XhoI restriction site underlined, stop codon bold, cysteine bold and underlined, His 6 -tag italic). For expression in mammalian cells, α-GFP as well as mCherry were PCR amplified and introduced into the pcDNA3.1(+) plasmid, resulting in a plasmid coding for α-GFP mCherry . fw 5'-GCGCGCGCTAGCACCATGCAGGTTCA GCTGGTTGAAAGCGG-3' (NheI restriction site underlined, start codon bold) and rev 5'-GCGCGCGGTACCGCTGCTA ACGGTAACCTGGGTGCCC-3' (Acc65I restriction site underlined) for the α-GFP nanobody and fw 5'-CGCGCGGTACCATGGTGAGCAAGGGCGAG GAGCTGTTC-3' (Acc65I restriction site underlined, start codon bold) and rev 5'-GCGCGCCTCGAGTTA CTTGTACAGCTCG TCCATGCCGAGAG-3' (XhoI restriction site underlined, stop codon bold) for mCherry. The α-Lamin nanobody was also inserted into the pET21a(+) plasmid and equipped with a His 6 -tag for purification. Using α-Lamin-EGFP as PCR template, α-Lamin was amplified, introducing a C-terminal cysteine (α-Lamin His6-Cys ), a N-terminal cysteine ( Cys α-Lamin His6 ), or replacing serine 9 by a cysteine (α-Lamin and mEGFP Lamin A was described previously (Kollmannsperger et al., 2016; Parcej et al., 2013) .
Protein purification
Two different protocols were used for purification. For α-GFP His6-Cys and α-Lamin His6-Cys expressed in E. coli BL21 (DE3), cell pellets were resuspended in lysis buffer (20 mM Tris pH 8.0, 100 mM NaCl, 1 mM phenylmethylsulfonyl fluoride (PMSF), 0.5 mM β-mercaptoethanol (β-ME)), followed by sonication for cell lysis. Cell debris were pelleted by ultracentrifugation (100,000x g, 30 min, 4 °C). For metal affinity chromatography, the supernatant was incubated with 3 ml Ni-NTA Sepharose beads (GE Healthcare) in the presence of imidazole (15 mM). Afterwards, the beads were washed in purification buffer (50 mM Tris pH 8.0, 300 mM NaCl, 50 mM imidazole, 0.5 mM β-ME). His-tagged proteins were eluted by 200 mM imidazole/purification buffer. Protein concentration was determined at A 280 . Buffer exchange to phosphate-buffered saline (PBS) containing 0.5 mM β-ME by Zeba spin desalting columns (7K) was followed by concentration via Amicon Ultra Filters
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(3 K). β-ME was directly removed before labeling the nanobodies using Zeba spin desalting columns (7K). Alternatively, nanobodies expressed in E. coli T7 Express were purified as described above, but at pH 7.5 and without β-ME.
Protein modification
Fluorescent dyes were either attached to the engineered cysteines or to lysines (only for α-Lamin His6-Cys ). The engineered cysteines of nanobodies stored in PBS without β-ME were reduced by incubation with 15 mM TCEP for 10 min on ice with subsequent buffer exchange by Zeba spin desalting columns (7K). Cysteine labeling was conducted following two different protocols: First, nanobodies were incubated with sulfo-Cy5 (sCy5) or sulfo-Cy3 (sCy3) maleimide in PBS (pH 7.4) for 1.5 h at 4 °C. Labeling was conducted at a protein concentration of approximately 1 mg/ml with 1.2-fold molar excess of the dye. Second, buffer was exchanged to maleimide labeling buffer after TCEP reduction (100 mM KH 2 PO 4 pH 6.4, 150 mM NaCl, 1 mM EDTA, 250 mM sucrose). Afterwards, the fluorophore was added in a 1.2-fold molar excess, immediately followed by neutralization to pH 7.5 using K 2 HPO 4 and 1.5 h incubation at 4 °C. For lysine labeling, nanobodies in PBS (pH 7.4) were mixed 1:20 with 0.1 mM NaHCO 3 (pH 9.0) to achieve pH 8.3 for labeling. Next, Alexa647 NHS ester was added with a 5-fold molar excess. Labeling was performed for 1 h at 20 °C before buffer exchange and removal of excess dye with Zeba spin desalting columns (7K, Thermo Scientific). Fluorescently labeled nanobodies were analyzed by SDS-PAGE and in-gel fluorescence (Typhoon 9400 Imager; l ex/em 630/670 nm). fNbs were finally purified by sizeexclusion chromatography in PBS using a KW404-4F column (Shodex; flow rate 0.3 ml/min).
All labeled nanobodies were stored in PBS at 4 °C. The nanobody-to-fluorophore ratio was 
Nanobody production
The nanobodies were produced in E. coli BL21 (DE3, Life technologies) or E. coli SHuffle T7
Express (New England Biolabs), whereas the latter contains a chromosomal copy of a disulfide isomerase, engineered to produce proteins with disulfide bonds in the cytosol. Both E. coli strains were transformed with the vectors, coding for α-GFP and α-Lamin nanobodies with engineered cysteines. A single colony was inoculated in LB medium containing 100 µg/ml ampicillin and 2% (w/v) glucose. After overnight incubation (37 °C for E. coli BL21
(DE3) and 30 °C for E. coli SHuffle T7 Express, 180 rpm), 1 l Lysogeny Broth (LB) medium with 100 µg/ml ampicillin was inoculated and protein expression was induced at A600 of 0.7-0.8 by 1 mM isopropyl-β-thiogalactopyranoside (IPTG, Sigma-Aldrich) and conducted for 5-20 h (30 °C, 180 rpm). After centrifugation (20 min, 4°C, 5,000x g), the cell pellets were directly used for protein purification or stored at -20 °C. 
Cell culture and transfection

HeLa
Cell fixation and labeling
Cells were washed with PBS (Sigma-Aldrich), fixed with 4% formaldehyde (Roth)/PBS for 10-20 min at 20 °C and permeabilized using 0.1% Triton X-100 (Roth)/PBS (10 min, 20 °C).
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After blocking with 5% (w/v) bovine serum albumin (BSA; Albumin Fraction V, Roth) in PBS for 1 h at 20 °C, cells were stained. Staining was performed with fNbs (diluted in 1% BSA/PBS) at concentrations ranging from 50 to 500 nM (indicated in each case).
Subsequently, cells were washed with PBS and optionally stained with 0.1 µg/ml 4',6-diamidino-2-phenylindole (DAPI, Sigma-Aldrich) in 1% BSA/PBS for 30 min to 1 h at 20 °C.
After washing with 5% BSA/PBS (3x), cells were post-fixed with 2% formaldehyde/PBS (15 min, 20 °C) and stored in PBS until imaging was performed.
Nanobody transfer by cell squeezing
Squeezing was performed using a chip with constrictions of 7 µm in diameter and 10 µm in length (CellSqueeze 10- (7)x1, SQZbiotech). In all microfluidic experiments, a cell density of 1.5 . 10 6 cells/ml in 10% (v/v) FCS/PBS was squeezed through the chip at a pressure of 30 psi. Transduction was conducted at 4 °C to block cargo uptake by endocytosis (Kollmannsperger et al., 2016) . During squeezing, the following fNb concentrations in the surrounding buffer were used: 100-200 nM of α-GFP, 200-500 nM of α-Lamin, and 50 µg/ml of α-Vimentin. After squeezing, cells were incubated for 5 min at 4 °C to reseal the plasma membrane. Squeezed cells were washed with DMEM containing 10% FCS, seeded into 8-well on cover glass II slides (Sarstedt) or collagen-coated dishes (µ-slide 8-well, Collagen IV coverslip, ibidi) in DMEM containing 10% FCS, and cultured at 37 °C and 5% CO 2 . Confocal imaging was performed 1 h and 20 h after squeezing. Squeezing experiments for live-cell protein labeling highly reproducible in at least three independent experiments for every POI.
Confocal laser scanning microscopy
Imaging was performed using the confocal laser scanning (LSM) microscope LSM880
(Zeiss) or TCS SP5 microscope (Leica) with Plan-Apochromat 63x/1. defined as the nearest neighbor distance in adjacent frames (Endesfelder et al., 2014) was calculated to 23.4 ± 8.3 nm for living and 23.2 ± 4.6 nm for fixed cells (mean and standard deviation of three individually analyzed cells, respectively) using LAMA software (Malkusch and Heilemann, 2016) . The average image used for visualization of nuclear intensity profiles in Figure 3c was generated by averaging the fluorescence intensity over 100 frames and After fixation, the endogenous nuclear lamina of HeLa Kyoto cells was visualized by 100 nM of α-Lamin ATTO655 fNb (red). 3D reconstruction of a z-stack showed a dense labeling of the nuclear lamina along with a high signal-to-background ratio (see Supplemental Video 1).
Super-resolution microscopy
Images were taken by CLSM with the Airy Scan detector. Scale bars: 5 μm. The α-Lamin nanobody was engineered with an extra single cysteine at three different positions, e.g. N-terminally (NT-Cys), C-terminally (CT-Cys), or at position 9 (S9C). After production in E. coli BL21/DE3 (a) or E. coli T7 SHuffle Express (b) and affinity purification, the engineered nanobodies were modified with maleimide sCy5 or ATTO655. Stochastic labeling via lysines exposed on the nanobody surface was conducted with NHS Alexa647.
The specificity of these fNbs was evaluated by staining of HeLa Kyoto cells (500 nM) after fixation and permeabilization. fNb target specificity was analyzed by CLSM. For the CT-Cys labeled, S9C labeled and Lys labeled fNbs a severe lack in target specificity was observed.
After production in E. coli T7 SHuffle Express and subsequent modification of the N-terminal cysteine in maleimide labeling buffer (MLB), specific tracing of endogenous lamin was achieved with greatly enhanced signal-to-background ratio. This fNb format was used for all further experiments. Scale bars: 20 µm. The α-Vimentin ATTO488 fNb was transferred into native HeLa Kyoto cells via cell squeezing.
Successful fNb delivery in multiple cells simultaneously was observed, demonstrating the high transduction efficiency of the cell squeezing approach. Imaging was performed 1 h after squeezing by CLSM. Scale bars: 20 µm.
